(CNS) Cohen Steers - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US19247A1007
CNS: Mutual Funds, Hedge Funds, Real Estate, Commodities, Fixed Income
Cohen & Steers, Inc. (NYSE: CNS) is a leading global investment manager with a distinct focus on real assets and alternative income strategies. Founded in 1986 and headquartered in New York, the firm has built a reputation for its expertise in navigating complex markets, particularly in sectors that require specialized knowledge.
The firm primarily serves institutional investors, including pension funds, endowments, and foundations, offering tailored solutions through its subsidiaries. Its investment strategies span equities, fixed income, commodities, and multi-asset portfolios, with a strong emphasis on sectors like real estate, infrastructure, and natural resources. Cohen & Steers is particularly known for its proficiency in preferred securities, a niche area that requires a deep understanding of market dynamics and structural nuances.
Through its subsidiaries, the company manages a diverse range of investment vehicles, including mutual funds, hedge funds, and separate accounts. This flexibility allows it to cater to the varied needs of its clients, from traditional equity and fixed-income strategies to more specialized approaches like commodity investing. Its global reach is evident in its ability to identify and capitalize on opportunities in both developed and emerging markets.
Cohen & Steers has established itself as a trusted partner for investors seeking exposure to real assets and alternative income streams. Its ability to balance risk and return in these often-volatile sectors has made it a go-to manager for institutions looking to diversify their portfolios. The firms long-term track record and specialized focus position it as a key player in the asset management industry.
From a financial perspective, Cohen & Steers operates with a market capitalization of approximately $4.39 billion, reflecting its significant presence in the market. The firms price-to-earnings ratio stands at 29.24, with a forward P/E of 30.12, indicating investor confidence in its future prospects. Its price-to-book ratio of 9.16 and price-to-sales ratio of 8.84 highlight its valuation relative to its assets and revenue.
For investors and fund managers, Cohen & Steers offers a compelling combination of expertise, diversification, and access to alternative income streams. Its focus on real assets and specialized sectors makes it a valuable addition to portfolios seeking stability and growth in uncertain markets.
Additional Sources for CNS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CNS Stock Overview
Market Cap in USD | 4,311m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 2004-08-13 |
CNS Stock Ratings
Growth 5y | 41.4% |
Fundamental | 34.2% |
Dividend | 51.9% |
Rel. Strength Industry | -3.89 |
Analysts | 3.67/5 |
Fair Price Momentum | 72.72 USD |
Fair Price DCF | 19.03 USD |
CNS Dividends
Dividend Yield 12m | 2.78% |
Yield on Cost 5y | 3.67% |
Annual Growth 5y | 1.69% |
Payout Consistency | 86.0% |
CNS Growth Ratios
Growth Correlation 3m | -90.4% |
Growth Correlation 12m | 78% |
Growth Correlation 5y | 48.4% |
CAGR 5y | 6.05% |
CAGR/Max DD 5y | 0.11 |
Sharpe Ratio 12m | 0.73 |
Alpha | 6.18 |
Beta | 0.87 |
Volatility | 30.16% |
Current Volume | 186.3k |
Average Volume 20d | 178.7k |
As of February 22, 2025, the stock is trading at USD 86.33 with a total of 186,333 shares traded.
Over the past week, the price has changed by +1.25%, over one month by -3.22%, over three months by -15.35% and over the past year by +24.98%.
Neither. Based on ValueRay Fundamental Analyses, Cohen Steers is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 34.18 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CNS as of February 2025 is 72.72. This means that CNS is currently overvalued and has a potential downside of -15.77%.
Cohen Steers has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold CNS.
- Strong Buy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CNS Cohen Steers will be worth about 87.3 in February 2026. The stock is currently trading at 86.33. This means that the stock has a potential upside of +1.09%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 93.3 | 8.1% |
Analysts Target Price | 97.7 | 13.1% |
ValueRay Target Price | 87.3 | 1.1% |